Applied BioCode Corp 6598
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 19.75
- Day Range
- TWD 19.20–19.80
- 52-Week Range
- TWD 19.20–28.40
- Bid/Ask
- TWD 19.70 / TWD 19.80
- Market Cap
- TWD 1.61 Bil
- Volume/Avg
- 70,497 / 59,653
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.08
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 43
- Website
- https://www.apbiocode.com
Comparables
Valuation
|
Metric
|
6598
|
300639
|
06667
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 68.38 | 98.21 |
Price/Book Value | 2.44 | 0.84 | 3.64 |
Price/Sales | 4.08 | 3.66 | 13.51 |
Price/Cash Flow | — | 19.36 | 56.52 |
Price/Earnings
6598
300639
06667
Financial Strength
|
Metric
|
6598
|
300639
|
06667
|
|---|---|---|---|
Quick Ratio | 6.46 | 5.86 | 5.66 |
Current Ratio | 8.24 | 6.25 | 5.84 |
Interest Coverage | −85.52 | 1.67 | 32.60 |
Quick Ratio
6598
300639
06667
Profitability
|
Metric
|
6598
|
300639
|
06667
|
|---|---|---|---|
Return on Assets (Normalized) | −14.02% | −0.07% | 2.84% |
Return on Equity (Normalized) | −21.55% | −0.09% | 3.36% |
Return on Invested Capital (Normalized) | −23.20% | −0.55% | 3.25% |
Return on Assets
6598
300639
06667
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ngwnbrzm | Gmctm | $184.2 Bil | |
SYK
| Stryker Corp | Qmypdmsbr | Jcnf | $125.1 Bil | |
MDT
| Medtronic PLC | Hjhgfwy | Bzxxg | $108.5 Bil | |
BSX
| Boston Scientific Corp | Hqclprbl | Wpfkrc | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Lwrkbpqxz | Kfnbftx | $51.4 Bil | |
DXCM
| DexCom Inc | Ssktzkmhn | Gyjb | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ylbplsxk | Lhlm | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Vdjgcltdh | Wtqjq | $24.4 Bil | |
ALGN
| Align Technology Inc | Pclnbqvcs | Synzm | $21.7 Bil | |
PODD
| Insulet Corp | Lmxtqcvjk | Lxpgzd | $12.2 Bil |